Article Information
- Received June 15, 2001
- Revision received September 4, 2001
- Accepted September 14, 2001
- First published December 1, 2001.
- Version of record published December 1, 2001.
Author Information
Author contributions
Disclosures
- Received June 15, 2001.
- Revision received September 4, 2001.
- Accepted September 14, 2001.
This work was supported by a grant on Specific Diseases (Itoyama) from the Ministry of Health and Welfare, Japan. Research funding was also provided to I.M. and N.K. by the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grants 11680816, 12794020), and to R.H.B. and P.P. by the National Institutes of Health (Grants PO1NS31248, PO1NS37912), the Myrtle May MacClellan ALS Research Foundation, the Pierre L. de Bourgknecht ALS Research Foundation, the Amyotrophic Lateral Sclerosis Association, the Muscular Dystrophy Association, Project ALS, the Angel Fund for ALS Research, and the Al Athel Foundation for ALS Research. We thank Drs. M. Ohira and A. Nakagawara for cloning the PAC clone used in this study, and Drs. T. Kitamoto and K. Abe for helpful discussions. We also thank R. Kamii and Y. Onodara for technical assistance and Dr. S. Kure for the measurement of amino acid levels in the CSF.
Correspondence should be addressed to Dr. Masashi Aoki, Department of Neuroscience, Division of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Sendai 980-8574, Japan. E-mail:aokim{at}mail.cc.tohoku.ac.jp.
Online Impact